If you can't see this email correctly, click here.
avance logo top image
News in Avance Your Source for Valuation header 3


Evolution of Valuation

Valuation has enormously evolved, but we are not always aware of it.

Before the rise of spreadsheets valuation was a cumbersome endeavour. Unfortunately, still many conclusions and work-arounds from that time have survived until today. Many textbooks, professors, and bosses date back to the valuation stone-age. It's time to accept that those dinosaurs are on the decline.

MORE>


25/10/2012 and 26/10/2012
License Contract and Company Valuation in Excel
Barcelona - Spain

15/11/2012 and 16/11/2012
License Contract and Company Valuation in Excel
New York - USA

P U B L I C A T I O N S

Survey about discount rates in pharma and biotech
Survey of industry professionals by Biostrat and Avance about the discount rates for biotech companies.

The effect of taxes on the value of start-up companies
Journal of Business Valuation and Economic Loss Analysis

Valuation Book

Valuation in Life Sciences 3rd Edition
"Valuation in Life Sciences. A Practical Guide" has become the industry reference book. It has now been released already in its 3rd edition.

Click here to order.



License Contract and Company Valuation:
2-day workshop in Barcelona

Avance holds a 2-days' workshop on company valuation in Barcelona (25/26 October). The first day will cover project and license valuation. On the second day we will touch company valuation with delicate topics like cost of capital, taxes, and Monte Carlo simulations. All topics will be put into practice with a case study in Excel.

Barcelona Workshop >



License Contract and Company Valuation:
2-day workshop in New York

As every year Avance also holds a 2-days' workshop on company valuation in the United States, this year in New York (15/16 November). The first day will cover project and license valuation. On the second day we will touch company valuation with delicate topics like cost of capital, taxes, and Monte Carlo simulations. All topics will be put into practice with a case study in Excel.

New York Workshop >


ri:val: Negotiate your deals with ri:val

ri:val has evolved from a valuation software to an important negotiation and planning tool. Clients from pharma, biotech, universities, and the investor community use ri:val to

  • Evaluate term sheets,
  • Elaborate counter-offers,
  • Read and interpret benchmark deals,
  • Value the company,
  • Run various clinical scenarios,
  • Define liquidity needs,
  • Plan resource allocation,
  • Compare different strategies.
 MORE >


You can sign up for News in Avance or change your e-mail address here.
[Abmeldelink]
Copyright: Avance, Basel GmbH - Bäumleingasse 2 - CH - 4051 Basel